Spacer

 
Licensing & Royalties >> Licensing Opportunities >> Technology Abstracts
spacer
 
Infectious Diseases - Diagnostics:

DateRef. No.Patent No.Title
1/11/2013E-222-2012/0 Transmission-Blocking Malaria Vaccine
1/11/2013E-088-2012/0 Methods and Composition for Identification of Variants of JC Virus DNA; An Etiologic Agent for Progressive Multifocal Leukoencephalopathy (PML)
1/11/2013E-273-2011/0 Cross-Reactive Dengue Fully Human Monoclonal Antibodies
9/12/2012E-042-2008/0 Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studies
8/31/2012E-078-2009/0 Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses
8/17/2012E-222-2010/1 Filovirus Vaccines and Diagnostics Based on Glycoprotein-Fc Fusion Proteins
8/1/2012E-194-2005/0 7,871,777The Medusa™ Sequencer: A DNA or RNA Sequencing Machine the Size of a Molecule
7/31/2012E-174-2005/0 8263360Novel Infrared (IR)-Transparent Hydrophilic Membrane That Can be Used for Filtration, Printing or Microarrays, and Cultivation of Bacteria and Other Microorganisms for Reagent-Free IR Spectroscopic Identification
7/31/2012E-259-2004/2
E-259-2004/3
7,888,003HIV-1 Infection Detection Assay for Seroconverted HIV-1 Vaccine Recipients
5/25/2012E-036-2010/1 Simple, Quantitative Sensitive High-throughput Antibody Detection for Lyme Disease
4/30/2012E-011-2010/0 Parvovirus B19 Codon Optimized Structural Proteins for Vaccine and Diagnostic Applications
4/30/2012E-093-2010/0 Diagnostic H5N1 Avian Influenza Virus Peptides
3/3/2012E-032-2010/1 Bacterially Expressed Influenza Virus Recombinant HA Proteins for Vaccine and Diagnostic Applications
2/21/2012E-271-2011/0 Influenza Vaccine
1/19/2012E-074-2011/2 Infectious Hepatitis E Virus Genotype 3 Recombinants — Prospective Vaccine Candidates and Vector System
1/18/2012E-188-2006/0 Method for Producing Significant Amounts of B19 Virus for Development of Killed or Attenuated Vaccines
1/11/2012E-076-1992/0 Clones Encoding Mammalian ADP-Ribosylarginine Hydrolases
1/9/2012E-153-2006/0 Immunogenic Tetrasaccharide of Anthrax Spores
9/29/2011E-231-2011/0 Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)
9/29/2011E-014-2011/0 Rapid Molecular Assays for Specific Detection and Quantitation of Loa Loa Microfilaremia
9/29/2011E-281-2010/0 Diagnostic Assays and Methods of Use for Detection of Filarial Infection
8/30/2011E-308-2008/0 A Vaccine for Shigella sonnei for Both Children and Adults
8/12/2011E-076-2011/0 Monoclonal Antibodies Against Poliovirus
8/2/2011E-056-2007/0 8,017,938Microarray Binding Sensors Using Carbon Nanotube Transistors
8/2/2011E-197-2010/0 Method to Create Vaccines for the Prevention of Flavivirus Infections by Targeting Micro-RNA
7/26/2011E-032-2011/0 Multivalent Vaccines for Rabies Virus and Filoviruses
4/29/2011E-067-2011/0 Improved Standard for Immune System Recovery Assay
2/28/2011E-049-2004/0 7,303,751Anti-Plasmodium Compositions and Methods of Use
2/28/2011E-003-1989/0 5,869,608
6,384,206
Nucleotide And Amino Acid Sequences Of The Four Variable Domains Of The Major Outer Membrane Proteins Of Chlamydia Trachomatis
2/28/2011E-139-2006/0 8,337,860Development of Dengue Virus Type 3 Vaccine Candidates
2/28/2011E-240-2007/0 Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine Candidates for the Prevention of Disease Caused by SLEV
2/28/2011E-031-2006/0 Chlamydia Vaccine
2/28/2011E-066-2003/5 7,622,113
8,337,853
Monoclonal Antibodies That Bind or Neutralize Dengue Virus
2/28/2011E-004-2004/2 20042011615
7,025,961
Anti-Plasmodium Compositions and Methods of Use
2/28/2011E-022-2004/0 7,851,194Live-Attenuated West Nile Virus Vaccines with Improved Immune Responses
2/28/2011E-089-2002/1 7,517,531
8,075,903
Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4
2/28/2011E-130-2002/0
E-189-2008/2
E-285-2002/0
7,485,306
7,741,437
Vaccines Comprising Sand Fly Salivary Proteins for Control of Leishmania Infection
10/29/2010E-156-2008/0 Insertion of Foreign Genes in Rubella Virus and their Stable Expression in a Live, Attenuated Viral Vaccine
7/2/2010E-039-1999/0 7,115,262A Novel Chimeric Bifunctional Protein for Prevention and Treatment of HIV Infection
6/14/2010E-236-2007/3 Immunogenic Peptides Against Influenza Virus
6/14/2010E-142-2008/0 Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use
6/14/2010E-317-2001/0 Discovery of Novel Inhibitors of HIV-1 Integrase That Can Be Used for the Treatment of Retroviral Infection Including AIDS
6/14/2010E-230-2002/2 7,482,133Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use
6/14/2010E-189-1998/0 Inhibitors of Formation of Protease Resistant Prion Protein
6/14/2010E-247-2002/1 Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis)
6/10/2010E-008-1996/0 C-C Chemokines That Inhibit Retrovirus Infection
6/3/2010E-152-2009/0 qPCR Assay for Detection of JC Virus
2/12/2010E-279-2007/0 Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use: Development of Pharmaceutical Agents and Improved Vaccines
2/12/2010E-280-2007/0 Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use: Development of Pharmaceuticals and Improved Vaccines
10/7/2009E-328-2001/1 Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth
9/3/2009E-169-2004/0
E-281-2005/0
E-318-2000/0
Rapid Diagnostic Applications of Phage
8/31/2009E-125-2008/0 Monoclonal Antibodies That React With the Capsule of Bacillus anthracis
8/14/2009E-063-2009/0 Antigen Mixtures for Serological Detection of HHV-8 Infection
8/11/2009E-010-1994/0 5,610,060Isolated Helicobacter hepaticus
7/14/2009E-249-2007/0 7,678,569A Unique Infectious Hepatitis C Virus Clone, Strain HC-TN (genotype 1a)
6/1/2009E-093-2000/0 6,905,822
7,547,519
Method of Diagnosing Multidrug Resistant Tuberculosis
12/1/2008E-029-2007/0 A Varicella-Zoster Virus Mutant that is Markedly Impaired for Latent Infection Available for the Development of Shingles Vaccines and Diagnostics
12/1/2008E-228-2002/0 Methods and Compositions for Selectively Enriching Microbes
10/1/2008E-145-2004/3 7,914,788Monoclonal Antibodies Against Orthopoxviruses
9/1/2008E-123-2007/0
E-146-2004/0
8,071,100Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF)
9/1/2008E-268-2002/0 7,261,900Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines
9/1/2008E-109-2007/1 8,216,788A Rapid Ultrasensitive Assay for Detecting Prions Based on the Seeded Polymerization of Recombinant Normal Prion Protein (rPrP-sen)
9/1/2008E-032-2008/0 Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax
8/1/2008E-141-2003/0 7,993,647Monoclonal Antibodies to HIV-1 Vpr
6/1/2008E-298-2007/0 Immunostimulatory Combinations of TLR Ligands and Methods of Use
10/1/2007E-263-2005/0 8,252,550Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
6/1/2007E-300-2002/0 Development of a Novel High Throughput Assay to Measure Cell-Infection with Vaccinia Strains Expressing Reporter Genes
11/1/2006E-091-1999/0 2259657
6,617,103
HSV-2 Diagnostic
11/1/2005E-104-2005/1 Furin Inhibitors and Alpha-Defensin for Preventing Papilloma Virus Infection
11/1/2005E-051-2005/0 Identification of a Fusion/Entry Receptor for Human Herpesvirus-8
9/1/2005E-184-2004/0 A Novel Amplification Method Permits Pathogens to be Detected with Microarrays
8/1/2005E-318-2000/0 Method for Determining Sensitivity to a Bacteriophage
6/1/2005E-238-2003/0 Detection and Identification of Mycobacterium Using SecA
4/1/2005E-022-2005/0 Methods for High-Efficiency Single Genome Sequencing of HIV
4/1/2005E-176-2003/0 Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria
12/1/2004E-004-2005/0
E-004-2005/4
7,988,971Human Monoclonal Antibodies Against Hendra and Nipah Viruses
12/1/2004E-299-2004/0 Vaccines Against Crimean-Congo Hemorrhagic Fever
6/1/2004E-228-2003/1
E-228-2003/2
Soluble SARS Coronavirus Spike Protein (S Protein)
1/1/2004E-041-2004/0 Codon-Optimization of the HIV-1 Vif Gene
1/1/2004E-324-2003/0 Streptococcus Lipoprotein Antigens
12/1/2003E-276-2003/0 HIV-Dependent Expression Vector
11/1/2003E-086-1999/0 6,875,855
7,332,167
Molecular Diagnosis of Disseminated Candida albicans Infection Using Hemoglobin-Response Gene
11/1/2003E-223-2002/0 Factors That Bind Intestinal Toxins
9/1/2003E-150-1994/0 5,622,861Hepatitis A Virus Receptor And Methods Of Use
1/1/2003E-144-2002/0
E-144-2002/1
7,566,451
7,803,913
8,110,192
vel Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Selected from Fab Phage Display Libraries Using a Novel Strategy Based on Alternative Antigen Panning
and
Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Single-Chain Antibodies Derived from X5 by DNA Shuffling and Alternating Antigen Panning
1/1/2002E-064-2001/0 6,951,761Parallel Measurements of Multiple Macromolecules Using a Cryoarray
11/1/2001E-304-1998/0 Recombinant Proteins of the Swine Hepatitis E Virus and Their Uses as a Vaccine and Diagnostic Reagents for Medical and Veterinary Applications
9/1/2001E-179-2001/0 Identification of a Cell-surface Receptor for Papillomaviruses
2/1/2001E-082-1996/0 Simian-Human HAV Chimeras Encoding a Hepatitis A Virus Having a Chimeric 2C Protein
4/1/2000E-200-1993/0
E-200-1993/1
6,039,957
6,171,596
Oligomeric HIV-1 Envelope Glycoproteins
2/1/1999E-034-1989/0 Probe To Identify Enteroinvasive E. coli And Shigella Species
9/1/1998E-141-1992/2 Recombinant Proteins Of A Pakistani Strain Of Hepatitis E And Their Use In Diagnostic Methods And Vaccines
7/1/1998E-276-1988/1 5,674,720Design And Construction Of Non-Infectious Human Retroviral Mutants Deficient In Genomic RNA
3/1/1998E-209-1997/0 6,600,030Delayed Progression To AIDS By A Missense Allele Of The CCR2 Gene
3/1/1998E-087-1997/0 STRL33, A Human Fusion Accessory Factor Associated With HIV Infection
10/1/1997E-056-1990/1 5,780,041Antigenic Protein Of Borrelia Burgdorferi
10/1/1997E-059-1990/0 6,709,811Versatile Reagent For Detecting Murine Leukemia Viruses
5/1/1997E-019-1993/0 5,449,608Parvovirus B19 Receptor And Parvovirus B19 Detection
4/1/1996E-454-1986/3 5,604,093
6,018,027
6,054,283
RE38824
Human B Lymphotropic Virus (HBLV) Isolation And Products
5/1/1995E-134-1994/0 Hepatitis C Virus Core Peptide For Stimulation Of Cytotoxic T Lymphocytes
5/1/1995E-032-1994/0 5,882,852
7,070,790
Nucleotide And Deduced Amino Acid Sequences Of The Envelope-1 And Core Genes Of Isolates Of Hepatitis C Virus And Methods Of Use
11/1/1994E-325-1983/2 5,516,630Production Of Complementary DNA Representing Hepatitis A Viral Sequences By Recombinant DNA Methods And Uses Therefor
2/1/1994E-032-1990/1 Method For Immune Capture And Primary Isolation Of Borrelia Burgdorferi
2/1/1994E-226-1989/0 5,489,511Specific And Sensitive Diagnostic Test For Lyme Disease
1/1/1994E-253-1993/0 5,709,996
5,716,620
5,744,142
5,756,284
5,871,998
5,985,610
Self-Assembling Recombinant Papillomavirus Capsid Proteins
Back Image: Return To Top

 
Spacer
Note that this site uses cookies, Click here for more information.